Trial Profile
A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Safety and Efficacy of Antibacterial Prophylaxis for Prevention of Infections in Azacitidine Treated Myelodysplastic Syndrome Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2023
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 23 Nov 2023 Status changed from recruiting to completed.
- 25 Jan 2018 Status changed from not yet recruiting to recruiting.
- 08 Dec 2016 New trial record